About Bio Elpida
Bio Elpida is a Healthcare company based in Lyon (France) founded in 2009, and was acquired by Polyplus Transfection in December 2022. Bio Elpida, a Biotechnology Contract Manufacturing Company for pre-clinical and clinical development of cell therapy products and bio-products. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Microbial Strains. Its competitors include Wacker Chemie, AMILI, Enduro, BioCina and Vibalogics and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Bio Elpida was founded in 2009 in Lyon, France, and functions as a biotechnology contract manufacturer. Pre-clinical and clinical development of cell therapy products and bio-products is undertaken. Core operations cover cell culture, bacterial fermentation, innovative cell therapy, and immunology. Services include feasibility studies, pharmaceutical development, manufacturing, testing, aseptic fill, formulation development, and analytical development.
- Headquarters Lyon, France
- SectorsHealthcare
- Website bio-elpida.com
- Social LinkedIn
- Acquired by Polyplus Transfection (Dec 2022)
- Investors
- Acquired byPolyplus Transfection
(Dec 2022)
Investors in Bio Elpida
Bio Elpida has secured backing from 1 investor. Prominent investors backing the company include Polyplus Transfection.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Transfection Solutions for Healthcare and Life Sciences organizations | 2001 | polyplus-transfection.com | Illkirch Graffenstaden, France |
Investor details for Bio Elpida
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bio Elpida
2 dated milestones of Bio Elpida across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Bio Elpida is founded.
- Exit Acquired by Polyplus Transfection.
Competitors of Bio Elpida
Bio Elpida has 10 listed competitors in our database, 4 of them funded. They include Wacker Chemie, AMILI, Enduro, BioCina and Vibalogics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wacker.com | 1914 | Munich, Germany | – | 1,509 | Silicones, polymers, and bio-solutions are manufactured for various industries. | |
| amili.asia | 2019 | Singapore | $10.5M | – | Gut microbiome insights, analytics, tests, and therapeutics are provided. | |
| enduro.bio | 2019 | Copenhagen, Denmark | $12.42M | 13 | Microbial strains are manufactured by Enduro as a CDMO. | |
| biocina.com | 2018 | Thebarton, Australia | – | – | CDMO offering microbial expression systems-based biologics development and manufacturing services | |
| vibalogics.com | 2007 | Cuxhaven, Germany | – | 89 | CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria | |
| elesztogenetika.com | 2008 | Budapest, Hungary | – | – | CDMO offers microbial expression systems-based biologics development | |
| xiaozaotech.com | 2016 | Shenzhen, China | $15.51M | – | Offers microbial expression systems-based biologics development and manufacturing services | |
| b2i.co.jp | 2020 | Kobe, Japan | – | – | Microorganism-based drugs are manufactured by this CDMO in Japan. | |
| bdibiotech.com | 2014 | Valladolid, Spain | $4.78M | – | Microbial strains for biopharma are developed at BDI Biotech. | |
| microbiome-cdmo.com | 1951 | Aurillac, France | – | – | Live biotherapeutic drugs are developed using microbiota and microbiome science. |
Detailed competitors of Bio Elpida
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Bio Elpida (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio Elpida
Complete news archive for Bio Elpida
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio Elpida
Bio Elpida was founded in 2009.
Bio Elpida is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Bio Elpida was founded in 2009 in Lyon, France, and functions as a biotechnology contract manufacturer. Pre-clinical and clinical development of cell therapy products and bio-products is undertaken. Core operations cover cell culture, bacterial fermentation, innovative cell therapy, and immunology. Services include feasibility studies, pharmaceutical development, manufacturing, testing, aseptic fill, formulation development, and analytical development.
Bio Elpida's top competitors include Wacker Chemie, AMILI and Enduro.
Bio Elpida has 1 investor. Key investors include Polyplus Transfection.
Yes. Bio Elpida was acquired by Polyplus Transfection in December 2022.